Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.500
0.00 (0.00%)
May 7, 2026, 3:43 PM HKT

HKG:2563 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-143.78-189.64-160.51-278.14
Depreciation & Amortization
9.2910.5610.468.65
Other Amortization
0.060.060.040.03
Asset Writedown & Restructuring Costs
---0.08
Loss (Gain) From Sale of Investments
0.2-9.1-10.85-22.39
Stock-Based Compensation
9.0644.480.74-
Provision & Write-off of Bad Debts
0.29-1.281.210.38
Other Operating Activities
-20.28-16.96-22.38245.59
Change in Accounts Receivable
-12.4925.22-6.9-20.92
Change in Inventory
-4.463.07-8.44-16.99
Change in Accounts Payable
17.53.3928.236.24
Change in Unearned Revenue
47.17-0.71-1.53-1.3
Change in Other Net Operating Assets
-5.29-19.7910.5-
Operating Cash Flow
-102.72-150.78-79.44-78.77
Capital Expenditures
-40.81-27.84-31.86-11.06
Sale (Purchase) of Intangibles
---0.82-
Investment in Securities
79.38145.98-114.11121.93
Other Investing Activities
15.6213.14-17.57
Investing Cash Flow
54.2131.28-146.79128.44
Short-Term Debt Issued
--0.07-
Total Debt Issued
--0.07-
Short-Term Debt Repaid
--0.07--
Long-Term Debt Repaid
-1.22-1.01-1.13-1.08
Total Debt Repaid
-1.22-1.07-1.13-1.08
Net Debt Issued (Repaid)
-1.22-1.07-1.06-1.08
Issuance of Common Stock
213.96--0.27
Other Financing Activities
-11.23-0.064.59-
Financing Cash Flow
201.52-1.133.53-0.81
Foreign Exchange Rate Adjustments
-1.37-1.3914.38-4.9
Net Cash Flow
151.63-22.02-208.3143.96
Free Cash Flow
-143.52-178.62-111.3-89.83
Free Cash Flow Margin
-199.71%-268.05%-339.12%-126.41%
Free Cash Flow Per Share
-0.41-0.51-0.32-0.26
Cash Interest Paid
0.060.060.07-
Cash Income Tax Paid
---1.08
Levered Free Cash Flow
-169.76-99.06-46.5423.12
Unlevered Free Cash Flow
-169.72-99.03-46.4923.16
Change in Working Capital
42.4411.1821.85-32.97
Source: S&P Global Market Intelligence. Standard template. Financial Sources.